FGFR3 and urothelial carcinoma: Urothelial carcinoma cells with FGFR3 mutations that are insensitive to pan-FGFR inhibitors (those containing the FGFR3S249C or FGFR3Y375C mutations) were found to be sensitive to Hsp90 inhibitors [162].